Jessica Merrill, Andrew McConaghie, and Mike Ramirez discuss key takeaways from the 2020 J.P. Morgan Healthcare Conference (JPM).

Topics covered in this episode include:

• Intro/general discussion of the meeting (0:00-4:17)

• Focus on execution at this year’s meeting (4:17-6:14)

• Companies that may be poised to make M&A deals in the near future (6:14-9:05)

• Potential reasons behind lack of M&A, including uncertainty around the U.S. election, valuation expectations (9:05-16:49)

• Discussion on drug pricing regulation (16:49-23:31)

• Sessions of particular interest (23:31-34:24)

To learn more about Scrip, Pink Sheet, Datamonitor Healthcare and other offerings from Pharma Intelligence, visit:

pharmaintelligence.informa.com/

Ver todos los episodios